(Q33916746)

30 July 2017

1 reference

title

Retroviral integrase inhibitors year 2000: update and perspectives (English)

1 reference

30 July 2017

Pommier Y

1

1 reference

PubMed ID

10974366

30 July 2017

Marchand C

series ordinal

2

1 reference

PubMed ID

10974366

30 July 2017

Neamati N

series ordinal

3

1 reference

30 July 2017

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

47

1 reference

30 July 2017

3

1 reference

30 July 2017

139-148

1 reference

The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

High affinity interaction of HIV-1 integrase with specific and non-specific single-stranded short oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Identification of a nucleotide binding site in HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Inhibitors of human immunodeficiency virus integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Integration complexes derived from HIV vectors for rapid assays in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Chicoric acid analogues as HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Potent inhibitors of human immunodeficiency virus type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Thiazolothiazepine inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

HIV-1 integrase inhibitors: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

4 Viral entry as the primary target of anti-HIV activity of chicoric acid and its tetra-acetyl esters

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Inhibitors of human immunodeficiency virus integrase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Synthetic DNA minor groove-binding drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

L-chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Structure and absolute stereochemistry of HIV-1 integrase inhibitor integric acid. A novel eremophilane sesquiterpenoid produced by a Xylaria sp.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Cell protein cross-linking by erbstatin and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Disruption of IRS-2 causes type 2 diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Inhibition of HIV integrase by novel nucleotides bearing tricyclic bases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900112-1

7 January 2021

10.1016/S0166-3542(00)00112-1

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10974366